EVENT – 2nd ISoP Seminar – “Intelligent Automation in Pharmacovigilance” December 2018

Dr Jan Petracek, PrimeVigilance CEO and ISoP Board member is organising the 2nd seminar on “Intelligent Automation in Pharmacovigilance” together with the International Society of Pharmacovigilance (ISOP), scheduled to take place on 3rd and 4th December 2018, in Boston/Cambridge, US.
This seminar follows last year’s very successful ISOP seminar on the same subject, which was hosted by Biogen.
About the seminar
Is Intelligent Automation a true game changer? This is the question that is likely to be on most industry expert’s minds. Given that the concept of Intelligent Automation is building momentum across other industries, and the prospect of a digital workforce being the new normal, is fast becoming reality.
Pharmacovigilance is full of daily repetitive tasks that are ideal for Intelligent Automation. There are many advantages for companies to adopt the use of this technology, such as, continuity enhancement – in most cases an automated process can cover 24 hours per day. This allows organisations the opportunity for repurposing staff on complex tasks that require in depth analysis and decision making, adding much greater value to the company. It will also strengthen overall job satisfaction, as employees should feel more engaged, working on new and challenging assignments, leading to less staff turnover. In addition, it can reduce time spent recruiting, interviewing and hiring; relieving the additional strain on key subject matter experts having to laboriously train new joiners to the company, and de-creasing the need for overtime hours. All these factors should consequently help to develop a strong stable workforce, by potentially achieving the all-important aspect of a work-life balance. In addition, automation increases quality assurance and compliance for the company, through consistency – the robot will always follow a certain process flow and will not deviate from the specifications, producing a very detailed audit log of all the actions being executed, thus facilitating audit requirements.
Last year, the International Society of Pharmacovigilance held a thought-provoking seminar – Intelligent Automation in Pharmacovigilance. Offering a unique, highly focused, scientific and interactive two-day event, 30 speakers across the pharma and technology services industry were invited to speak on this hot topic, and the feedback gathered from the attendees at the seminar was very positive. Interesting, engaging and, at times, controversial debates were sparked during the open panel discussions.  One year later, we now have the opportunity to share our experiences, challenges, successes and more importantly the lessons learned that we have all encountered so far on our “Intelligent Automation” journey.
There will be ample opportunity to exchange views and ideas in discussions both following individual presentations, after the panel discussion at the end of the seminar, and during coffee breaks.
The faculty will consist of international experts in pharmacovigilance, representing government, academia, and industry.
The seminar will be held in Boston (USA), Massachusetts’ capital. Training certificates of attendance will be provided to those who complete the seminar.
Save the date and register your interest!
Click here for final  agenda
For more information and to register please go to  ISoP website

First Name

Last Name

Job Title

Company

Email

How did you discover our company
—Please choose an option—Search enginesSocial mediaConference or tradeshowReferral or word of mouthWebinarInternet adsOther

Meeting Date

“By submitting this form, you consent to your personal data being processed in alignment with our privacy policy. Your personal data will be processed for purpose of facilitating your request and may be used for sending you additional marketing and business development-related information about PrimeVigilance, its affiliates and our services. You can withdraw your consent at any time at marketing@ergomedgroup.com, and your personal data will be erased. For more information about our privacy policy and your privacy rights, please visit our website’s data policy section.

5341